Balance Sheet - Inhibrx Biosciences, Inc. (INBX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 124.22 | 152.60 | 277.92 | 273.87 | 131.30 | 128.66 | 11.54 | 2.10 | 13.47 | 20.03 |
| Accounts receivable, net | 0.18 | 0.42 | 0.78 | 0.26 | 0.88 | 0.62 | 0.44 | 0.69 | 0.70 | |
| Inventories | -0.26 | -0.88 | -129.28 | 3.21 | 2.31 | 1.00 | ||||
| Other current assets | 8.43 | 7.38 | 16.66 | 6.37 | 7.81 | 132.17 | 0.38 | 0.55 | 0.28 | 0.38 |
| Total current assets | 132.83 | 160.40 | 295.36 | 280.49 | 139.11 | 132.17 | 15.56 | 5.66 | 15.44 | 20.41 |
| Total non-current assets | 13.65 | 20.37 | 12.54 | 10.38 | 11.34 | 11.57 | 10.93 | 4.33 | 1.81 | 0.86 |
| Total assets | 146.48 | 180.77 | 307.89 | 290.88 | 150.45 | 143.74 | 26.49 | 9.98 | 17.25 | 21.27 |
| Total current liabilities | 33.80 | 40.73 | 56.31 | 27.58 | 22.45 | 31.40 | 20.57 | 16.18 | 8.92 | 5.28 |
| Total non-current liabilities | 104.69 | 6.45 | 208.08 | 205.24 | 75.61 | 36.87 | 99.49 | 51.45 | 30.75 | 14.75 |
| Total liabilities | 138.49 | 47.18 | 264.39 | 232.82 | 98.07 | 68.27 | 120.06 | 67.63 | 39.67 | 20.03 |
| Total stockholders' equity | 7.99 | 133.58 | 43.50 | 58.06 | 52.38 | 75.47 | -93.57 | -57.64 | -28.77 | -9.25 |
| Common shares outstanding | 15 | 14 | 47 | 40 | 38 | 25 | 37 | 27 | 29 | 37 |
Show Quarterly Balance Sheet
Balance Sheet - Inhibrx Biosciences, Inc. (INBX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Jun-18 | Mar-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 161.66 | 124.22 | 153.09 | 186.57 | 216.52 | 152.60 | 196.33 | 226.86 | 252.48 | 277.92 | 337.33 | 192.49 | 234.25 | 273.87 | 146.07 | 176.39 | 143.47 | 131.30 | 112.70 | 125.73 | 107.99 | 128.66 | 127.67 | 5.63 | 0.43 | 11.54 | 0.00 | 27.63 | 6.24 | 2.10 | 0.00 | 13.47 | 13.47 |
| Accounts receivable, net | 0.19 | 0.18 | 0.84 | 0.97 | 0.21 | 0.42 | 1.13 | 1.39 | 3.04 | 0.78 | 0.33 | 0.33 | 0.30 | 0.26 | 0.32 | 0.28 | 0.43 | 0.88 | 0.50 | 0.53 | 0.36 | 0.62 | 0.96 | 0.12 | 0.44 | 4.34 | 1.78 | 0.69 | 0.70 | ||||
| Inventories | -0.33 | 10.18 | -0.30 | -0.26 | -0.32 | 5.90 | -0.88 | 5.08 | 4.40 | 4.38 | -129.28 | -0.96 | 2.75 | 3.21 | 1.67 | 2.20 | 2.31 | 1.00 | |||||||||||||||
| Other current assets | 9.50 | 8.43 | 7.50 | 6.43 | 6.65 | 7.38 | 9.99 | 13.81 | 19.02 | 16.66 | 25.97 | 10.50 | 9.52 | 6.37 | 7.68 | 4.95 | 0.60 | 7.81 | 0.75 | 0.62 | 0.68 | 132.17 | 4.18 | 0.30 | 2.93 | 0.38 | 0.50 | 0.27 | 0.55 | 0.28 | |||
| Total current assets | 171.34 | 132.83 | 161.42 | 193.96 | 223.39 | 160.40 | 207.45 | 242.06 | 274.54 | 295.36 | 363.30 | 203.32 | 243.78 | 280.49 | 153.75 | 181.62 | 150.40 | 139.11 | 119.03 | 131.28 | 113.40 | 132.17 | 131.85 | 8.80 | 3.36 | 15.56 | 34.14 | 10.49 | 5.66 | 13.47 | 15.44 | ||
| Total non-current assets | 12.63 | 13.65 | 16.05 | 18.15 | 19.25 | 20.37 | 15.12 | 16.36 | 14.04 | 12.54 | 9.44 | 9.85 | 9.94 | 10.38 | 11.10 | 11.59 | 10.78 | 11.34 | 10.15 | 10.61 | 11.10 | 11.57 | 11.70 | 12.50 | 12.21 | 10.93 | 14.60 | 13.54 | 4.33 | -13.47 | 1.81 | ||
| Total assets | 183.97 | 146.48 | 177.47 | 212.12 | 242.64 | 180.77 | 222.56 | 258.42 | 288.58 | 307.89 | 372.73 | 213.17 | 253.72 | 290.88 | 164.85 | 193.21 | 161.18 | 150.45 | 129.18 | 141.89 | 124.50 | 143.74 | 143.55 | 21.30 | 15.57 | 26.49 | 48.73 | 24.03 | 9.98 | 17.25 | |||
| Total current liabilities | 26.51 | 33.80 | 35.98 | 38.94 | 43.64 | 40.73 | 44.10 | 39.05 | 71.87 | 56.31 | 35.77 | 31.33 | 32.64 | 27.58 | 25.43 | 24.20 | 20.11 | 22.45 | 25.15 | 21.67 | 27.85 | 31.40 | 34.74 | 29.78 | 25.24 | 20.57 | 14.82 | 17.56 | 16.18 | 8.92 | |||
| Total non-current liabilities | 178.49 | 104.69 | 104.66 | 104.62 | 104.56 | 6.45 | 0.00 | 0.00 | 205.14 | 208.08 | 207.37 | 206.65 | 205.94 | 205.24 | 174.48 | 173.93 | 113.73 | 75.61 | 75.83 | 75.90 | 36.06 | 36.87 | 17.09 | 10.77 | 43.39 | 99.49 | 93.16 | 67.05 | 51.45 | 30.75 | |||
| Total liabilities | 205.00 | 138.49 | 140.64 | 143.56 | 148.20 | 47.18 | 44.10 | 39.05 | 277.01 | 264.39 | 243.14 | 237.98 | 238.58 | 232.82 | 199.90 | 198.13 | 133.83 | 98.07 | 100.98 | 97.57 | 63.91 | 68.27 | 51.83 | 40.55 | 68.63 | 120.06 | 107.98 | 84.61 | 67.63 | 39.67 | |||
| Total stockholders' equity | -21.04 | 7.99 | 36.83 | 68.56 | 94.44 | 133.58 | 178.47 | 219.37 | 11.57 | 43.50 | 129.60 | -24.81 | 15.13 | 58.06 | -35.05 | -4.92 | 27.35 | 52.38 | 28.20 | 44.32 | 60.59 | 75.47 | 91.73 | -19.24 | -53.07 | -93.57 | -59.24 | -60.58 | -57.64 | -1.37 | -28.77 | ||
| Common shares outstanding | 16 | 15 | 15 | 15 | 15 | 14 | 15 | 15 | 55 | 54 | 47 | 44 | 44 | 43 | 39 | 39 | 39 | 39 | 38 | 38 | 38 | 38 | 27 | 36 | 29 | 29 | 29 | 29 | 29 | 28 | 29 | 29 | 18 |